ArticleInsights into imaging2025
A deep learning model based on self-supervised learning for identifying subtypes of proliferative hepatocellular carcinoma from dynamic contrast-enhanced MRI.
Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Hybrid Fusion of Time-Intensity Curve, Deep Learning, and Fractional Zernike-Caputo Features for Accurate Liver Lesion Classification in DCE-MRI.Journal of imaging · 2026Article
- Pioneering efficient deep learning architectures for enhanced hepatocellular carcinoma prediction and clinical translation.World journal of gastrointestinal oncology · 2026Article
- Automated abdominal aortic calcification scoring via deep learning: a multi-center validation of LVLCRNet.BMC medical imaging · 2025Article
- From texture analysis to artificial intelligence: global research landscape and evolutionary trajectory of radiomics in hepatocellular carcinoma.Discover oncology · 2025Article
- Decision-Making Biomarkers Guiding Therapeutic Strategies in Hepatocellular Carcinoma: From Prediction to Personalized Care.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesThis study employs dynamic contrast-enhanced MRI (DCE-MRI) to noninvasively predict the proliferative subtype of hepatocellular carcinoma (HCC). This subtype is marked by high tumor proliferation and aggressive clinical behavior. We developed a deep learning prediction model that employs a dynamic radiomics workflow and self-supervised learning (SSL). The model analyzes temporal and spatial patterns in DCE-MRI data to identify the proliferative subtype efficiently and accurately. Our goal is to improve diagnostic precision and guide personalized treatment planning.
methodsThis retrospective study included 381 HCC patiephonnts who underwent curative resection at two medical centers. The cohort was divided into the training (n = 220), internal (n = 93), and external (n = 68) test sets. A DL model was developed using DCE-MRI of the primary tumor. Class activation mapping was used to interpret HCC proliferation in HCC.
resultsThe pHCC-SSL model performed well in predicting HCC proliferation, with a training set AUC) of 1.00, an internal test set AUC of 0.91, and an external test set AUC of 0.94. Without SSL pre-training, the AUC for internal and external testing decreased to 0.81 and 0.80, respectively. The predictive performance of the derived model was superior to that of the current single-sequence model.
conclusionsThe pHCC-SSL model employs dynamic radiomics and a two-stage training approach to efficiently predict HCC proliferation from multi-sequence DCE-MRI, surpassing traditional single-stage models in accuracy and speed. CRITICAL RELEVANCE STATEMENT: Our study introduces the pHCC-SSL model, a self-supervised deep learning approach using DCE-MRI that enhances the diagnostic accuracy of HCC subtypes, significantly advancing clinical radiology by enabling personalized treatment strategies. KEY POINTS: The proposed model enables noninvasive identification of HCC with high proliferation and aggressive behavior. SSL improves lesion differentiation by reducing redundancy and enhancing feature diversity. Dynamic feature extraction captures vascular infiltration, aiding preoperative metastasis risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.